The report is updated with the impact of the COVID-19 pandemic on the Direct-to-Consumer Genetic Testing market. Every industry vertical across the globe has been affected by the pandemic, and the report assesses if the impact of the pandemic on the Direct-to-Consumer Genetic Testing market has been positive or negative.
Emergen Research has recently published a detailed report on the global Direct-to-Consumer Genetic Testing market formulated through extensive primary and secondary research. The report offers in-depth knowledge and analysis of the Direct-to-Consumer Genetic Testing market through verified and validated data curated to offer accurate insights.
The global Direct-to-Consumer Genetic Testing Market is forecasted to reach USD 3.33 Billion by 2027, according to a new report by Emergen Research. Increasing genetic disease incidence would fuel competition for direct-to-consumer genetic testing and accelerate market development across the expected timeframe. Increasing cases of hereditary disorders such as breast cancer, achondroplasia, colorectal cancer and other diseases have increased the need for cost-effective and reliable avenues of genetic testing in the healthcare industry. For reference, according to the World Cancer Research Fund (WCRF), more than 2 million new cancer cases were reported globally in 2018. Breast cancer is now considered to be the second most prevalent disease. The introduction of a superior standard and innovative direct-to-consumer genetic testing has significantly lowered mortality levels of people with cancer by maintaining diligence surveillance data even before the onset of the disease. The preceding conditions would, therefore, accelerate the demand for direct-to-consumer genetic testing to reverse the timetable for the prediction.
Get Free Sample Report @ https://www.emergenresearch.com/request-sample/20
The report further divides the Direct-to-Consumer Genetic Testing market into key segments such as types, applications, end-user industries, technologies, and key regions of the market. The report also sheds light on the segment and region exhibiting promising growth in the Direct-to-Consumer Genetic Testing market.
Direct-to-Consumer Genetic Testing Market Segmentation:
-
Test Type Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Carrier Testing
- Predictive Testing
- Ancestry & Relationship Testing
- Nutrigenomics Testing
- Others
-
Distribution Channel Outlook (Volume, Kilotons; 2017-2027, Revenue, USD Billion; 2017-2027)
- Online Platforms
- Over-the-Counter
-
Application Outlook (Volume, Kilo Tons; 2017-2027) (Revenue, USD Billion; 2017-2027)
- Targeted Analysis
- Single Nucleotide Polymorphism Chips (SNP)
- Whole Genome Sequencing (WGS)
Request a discount on the report @ https://www.emergenresearch.com/request-discount/20
The report also studies the key companies of the Direct-to-Consumer Genetic Testing market along with analysis of their business strategies, M&A activities, investment plans, product portfolio, financial standing, gross profit margin, and production and manufacturing capacities. Some players analyzed in the report are:
Key companies operating in the Direct-to-Consumer Genetic Testing market include:
23andMe, Full Genome Corporation, Color Genomics, Genesis Healthcare, Helix OpCo LLC, FamilyTreeDNA, MyHeritage, Identigene, Pathway genomics, and Living DNA, among others
The Global Direct-to-Consumer Genetic Testing Report is a panoramic study of the overall Direct-to-Consumer Genetic Testing market published by Emergen Research and covers a wide-ranging analysis of the technological advancements and product developments in the Direct-to-Consumer Genetic Testing market. The report provides a detailed analysis of the key factors of the Direct-to-Consumer Genetic Testing market that are expected to have a positive impact on the growth of the Direct-to-Consumer Genetic Testing industry.
Regional Segmentation
North America (U.S., Canada)
Europe (U.K., Italy, Germany, France, Rest of EU)
Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
Latin America (Chile, Brazil, Argentina, Rest of Latin America)
Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)
The report further examines the market in the key regions of the world with regard to production and consumption patterns, import/export, supply and demand ratio, revenue generation, market share and size, and presence of prominent players in the regions. The report also covers the expansion plans undertaken by companies in the regions under the regional analysis section.
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/direct-to-consumer-genetic-testing-market
Thank you for reading our report. Customization of this report is available as per the client’s requirements. Please connect with us to know more about the report, and our team will ensure you get the report tailored according to your needs.
About Us:
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights